(Total Views: 619)
Posted On: 05/28/2020 4:17:55 PM
Post# of 148984
FDA dragging its feet to give approval in lieu of giving EUA first doesn't make sense.
From the CC, I think NP said ~140k doses would come available around the end of July and the million(s) of doses would trickle in over the next 12 months. They could use this scenario as justification for wanting more trial data for approval and issue EUA for the leronlimab that is in stock now and what will come available at the end of July.
From the CC, I think NP said ~140k doses would come available around the end of July and the million(s) of doses would trickle in over the next 12 months. They could use this scenario as justification for wanting more trial data for approval and issue EUA for the leronlimab that is in stock now and what will come available at the end of July.
(0)
(0)Scroll down for more posts ▼
